Search Results

Clinical Trials: Why They Matter and How to Make Them More Accessible

Cancer treatments can be lifesaving. As an organization, The Leukemia & Lymphoma Society (LLS) has invested more than $1.7 billion in blood cancer res…

LLS Expands its Global Master Trial for Hard-To-Treat Leukemias in Children

Marks the First-Ever Global Pediatric Trial for Menin InhibitorsThe PedAL (Pediatric Acute Leukemia) Master Trial is at the heart of LLS’s Dare to Dre…

News Release

Defining and Redefining a Blood Cancer Diagnosis

Science historian June Goodfield wrote, “Cancer begins and ends with people.” This Blood Cancer Awareness Month, it’s important to know that The Leu…

Researchers Share Key Career Advice with LLS College Club Members

I recently had the privilege of moderating an LLS on Campus Researcher Panel attended by LLS college club members from nearly 30 universities across t…

The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member

News Release

BioInvent Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program and Receives $3 Million Strategic Equity Investment

Lund, Sweden – January 17, 2023 – BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and de…

Meet The Researcher: Dr. Rayne Rouce

To commemorate Black History Month, LLS is highlighting exceptional clinicians and healthcare professionals throughout the month of February. Dr. Rayn…

The Leukemia & Lymphoma Society Makes Fast Company’s Fifth Annual List of the Best Workplaces for Innovators in Nonprofit Category

News Release

We Dare to Dream so Their Dreams Come True

Did you know that blood cancer is the most common cancer diagnosis for children, accounting for 40% of pediatric cancer cases? In fact, nearly 55,000 …

Magrolimab Demonstrates Clinical Responses in Ongoing Phase 1b Trial of Previously Untreated Acute Myeloid Leukemia Patients

December 06, 2020 - FOSTER CITY, Calif. - Gilead Sciences, Inc. (Nasdaq: GILD) today announced updated results from the magrolimab Phase 1b trial. Mag…

FDA Approves a CAR T-cell Therapy to Treat Adults with a Form of Acute Leukemia

The Leukemia & Lymphoma Society (LLS) was an early champion and funder of CAR T-cell therapy Rye Brook, N.Y., December 6, 2024 – The U.S. Food and Dru…

FDA Approves First of a New Class of Drugs to Treat Advanced Acute Leukemia

The Leukemia & Lymphoma Society (LLS) helped every step of the way in discovery and development of menin inhibitors Rye Brook, N.Y., December 6, 2024 …

MOD PIZZA PARTNERS WITH THE LEUKEMIA & LYMPHOMA SOCIETY TO HELP KIDS WITH BLOOD CANCER

Funds Raised to Benefit the Work of LLS’s The Dare to Dream Project to Bring Safer, Less Toxic Treatments for Kids with Blood Cancer & Provide Free Su…

Targeting Oncoembryonic Antigens ROR1 and ROR2 For Therapy Of Patients With Hairy Cell Leukemia

We will study the function of ROR1 and ROR2 on HCL cells that we have collected from 120 patients, examining whether they influence expression of gene…

THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) INVESTS $3.8 MILLION TO ADVANCE HEALTH EQUITY

LLS’s Equity in Access Research Program Awards Five New Grants to Researchers Across the U.S. Aiming to Break Down Barriers to Care for Blood Cancer P…

News Release

The Leukemia & Lymphoma Society's Birmingham Light The Night Walk to be Chaired by Regions Executives

The Leukemia & Lymphoma Society's Birmingham Light The Night Walk to be Chaired by Regions Executives FRIDAY, FEBRUARY 4, 2010 ? The Ala…

A Message From Dr. Louis J. DeGennaro, President and CEO of The Leukemia & Lymphoma Society

One of the things that I value most about leading The Leukemia & Lymphoma Society (LLS) is seeing our talented, dedicated and relentless staff and vol…

The Leukemia & Lymphoma Society Applauds Bipartisan Agreement to Stop Surprise Medical Bills

Patients are now one step closer to breathing a sigh of relief. For too long, they’ve faced the anxiety of knowing that any visit to a healthcare prov…

News Release

The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia

For Immediate ReleaseContact: Andrea GreifSenior Director of Communications(914)821-8958 (p)914)772-3027 (c)[email protected](White Plains, NY) - J…

News Release

Burlington Stores and The Leukemia & Lymphoma Society: A Powerful Partnership that Helps to Save Lives

LLS Contact: Kristin Hoose [email protected] Stores Contact: Bari Kurzman212-522-2121

LLS Releases Results of its Precision Medicine Trial in Deadly Leukemia at ASH

100 View full release here. no-float …

News Release

Faron Announces Results of Placing, Including Additional Investment by The Leukemia & Lymphoma Society Therapy Acceleration Program®

TURKU, FINLAND / BOSTON, MA - January 27 2023 - Faron Pharmaceuticals Ltd (First North: FARON, AIM: FARN), a clinical stage biopharmaceutical company …